Riskpilot← Back to searchSign inGet full accessMaBio Oy
OYActiveY-tunnus 2428578-4Osuuskunnantie 33-B14Muu liikkeenjohdon konsultointi · NACE 70220Est. 20110 employeeswww.mabio.fi
Revenue 2021
EUR 0
EBITDA margin
—
-496% vs 2020
Equity ratio
82.0%
Financial strength
Net profit 2021
EUR -739
-501% vs 2020
| Revenue | EUR 0 | — |
| EBITDA | EUR -739 | -496% |
| Net profit | EUR -739 | -501% |
| Total assets | EUR 3K | -21% |
| Equity | EUR 2K | -25% |
| Employees | 0 | — |
Legal name
MaBio Oy
Y-tunnus number
2428578-4
Legal form
Osakeyhtiö
NACE code
70220 · Muu liikkeenjohdon konsultointi
Founded
12. syyskuuta 2011
Share capital
EUR 2 500
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Yhtiön toimiala on muu liikkeenjohdon konsultointi -tarkemmin kuvattuna luomutuotteiden ja palveluiden markkinointiviestinnän konsultointi ja toteutus sekä luomumarkkinoiden kehittämiseen liittyvät asiantuntijatehtävät.
Address
Osuuskunnantie 33-B14
Phone
+358207418940
Email
marika.auersalmi@mabio.fi
Website
www.mabio.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Revenue | 0 | — | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −0 | −0 | −0 | −1 |
| Depreciation & amort. | −0 | −0 | — | — |
| EBIT | −1 | −0 | −0 | −1 |
| Net financials | — | — | −0 | — |
| Profit before tax | −1 | −0 | −0 | −1 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −1 | −0 | −0 | −1 |
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Total assets | 4 | 3 | 3 | 3 |
| Equity | 3 | 3 | 3 | 2 |
| Long-term debt | — | — | — | — |
| Short-term debt | 0 | 0 | 0 | 0 |
| Total debt | 0 | 0 | 0 | 0 |
EBITDA margin
-73900.0%
This company
15.8%
Market median
-467822% vs market
20182021
Equity ratio
82.0%
This company
38.2%
Market median
+115% vs market
20182021
Return on equity
-32.7%
This company
18.4%
Market median
-278% vs market
20182021
Net profit margin
-73900.0%
This company
8.1%
Market median
-912446% vs market
20182021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182021
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20182021
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AI Liquidator | Liquidator | 2021 |
| Former (2) | ||
MM Chief Executive Officer | Chief Executive Officer | 2011 – 2021 |
TP Deputy Member | Deputy Member | 2011 – 2021 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MaBio Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marika Marja-Liisa Auersalmi | Chief Executive Officer | 0 companies |
| Tomi Petri Olavi Auersalmi | Deputy Member | 0 companies |
| Antti Ilari Karhinen | Liquidator | 0 companies |